Protalix BioTherapeutics (PLX)
Add to Watchlists Create an Alert
5.20
-0.01 -0.19%
AMEX
May 23, 8:00PM
BATS Real time
Currency in USD
Pro Data Export
Protalix BioTherapeutics Key Statistics
Currency in USD
Current Valuation
Dividends and Shares
| Shares Outstanding | 93.50M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | 0.10 |
| Last Split Date | Jan. 3, 2007 |
Profitability
| Gross Profit Margin Quarterly | -228.7% |
| Profit Margin Quarterly | -1999% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 2.375 |
| Debt to Equity Ratio | |
| Free Cash Flow | 1.57M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -7.14% |
| Year to Date Stock Returns | 0.19% |
| 1 Year Stock Returns | -15.31% |
| 3 Year Stock Returns | -14.33% |
| 52 Week High | 6.80 |
| 52 Week Low | 4.71 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 26.56M |
| Cash from Investing TTM | -2.286M |
| Cash from Operations TTM | 0.635M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 52.04M |
| Long Term Debt | 0.00 |
| Total Assets | 78.73M |
| Liabilities | 82.08M |
| Shareholders Equity | -3.357M |
| Book Value | -3.357M |
| Book Value Per Share | -0.0359 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
PLX News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PLX | 5.20 | -0.01 | -0.19% | 486.22M |
New watchlist
